The concern of generic competition has long loomed above copyright’s iconic drug, Sildenafil, triggering questions about the future of related medicinal stakes. While first periods saw significant returns, the exclusivity lapse has created the way for less expensive copies, likely lowering profitability and presenting a significant danger website